TIRZEPATIDE 26 MG/ML INJECTABLE — Class II drug recall D-0017-2027
Ongoing recall by Carolina Infusion, LLC, reported 2026-10-14, distributed nationwide. Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipme
| Recall number | D-0017-2027 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Carolina Infusion, LLC, Ridgeland, SC, United States |
| Recall initiated | 2026-09-10 |
| Classified | 2026-10-08 |
| Reported by FDA | 2026-10-14 |
| Distributed | Nationwide (US) |
| Quantity | 5.6 mls |
| Reason classes | sterility |
| Expiration dates | 2026-09-17, 2026-09-19, 2026-09-21, 2026-10-16 |
Product
TIRZEPATIDE 26 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936;
Reason for recall
Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0017-2027. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-10-21. Not affiliated with or endorsed by FDA. Not medical or legal advice.